Digital Transformation in Life Sciences: Navigating the Future with SAP and Vistex - Futurum Tech Webcast

On this episode of the Futurum Tech Webcast – Interview Series, host Daniel Newman welcomes Mandar Paralkar, Global VP, Life Sciences & Healthcare at SAP and Sandra Garitonandia, Industry Principal for Life Sciences at Vistex EMEA, for a conversation on digital transformation and the role of technology in navigating the future of Life Sciences and Healthcare. Their discussion covers: The key areas within life sciences companies where digital transformation is a priority, and why these areas are being targeted for transformation Successful approaches, strategies, and best practices that Life Sciences companies are adopting to optimize their revenue streams The impact of the size of a company, in terms of revenue and number of employees, on the approach to digital transformation How technology partners, like SAP and Vistex, are supporting life sciences organizations in their digital transformation journeys Insights into how digital transformation is helping life sciences organizations meet sustainability goals, especially in terms of reducing environmental impact Learn more about SAP and Vistex innovative solutions for the life science industry here.

Om Podcasten

Futurum Tech Webcast Leading tech analysts from The Futurum Group share weekly deep dives on the latest tech news, new products and services, mergers, earnings, regulations, and more. The Futurum Tech Webcast will keep you current on what’s happening in the tech space — from startups to industry leaders, emerging tech, and what’s ahead for industries across the globe, along with interviews with tech industry leaders and experts. Subscribe now and stay connected to this exciting journey into the world of technology and the future of work. For more information, visit https://www.futurumgroup.com As a reminder, the Futurum Tech Webcast is intended as an informational webcast/podcast only. While publicly traded companies and equities are frequently discussed, the analysts on this show are not in any way offering financial or investment advice.